Machine learning to predict lung cancer involvement of lymph nodes
AssigneeJohnson & Johnson Enterprise Innovation Inc.
InventorsGeorge R. Washko, JR., Raul San Jose Estepar, Charles Matthew Kinsey, Christopher Scott Stevenson
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for determining a subject level risk of metastatic cancer involving the training and/or deployment of models to determine 1) a lymph node level risk of individual lymph node involvement and/or 2) a subject level risk of lymph node involvement. Thus, the methods can identify patients who are high or low risk for having nodal disease and optionally enable the guided intervention of cancer patients, for example, via treatment.
Claims118
A method of determining a subject level risk of metastatic cancer of a subject, the method comprising:
- obtaining one or more images captured from the subject comprising a plurality of lymph nodes of the subject;
- and
- predicting the subject level risk of metastatic cancer by applying a risk model to extracted features of the obtained one or more images, the risk model trained to predict lymph node (LN) level risks of metastatic cancer for lymph nodes in images,
- wherein the risk model is trained using at least labels derived from imputed LN-level risks of metastatic cancer for a set of lymph nodes of a reference individual, the imputed LN-level risks of the set of lymph nodes determined using at least an imputation model that discriminates between cancerous and non-cancerous lymph nodes of training images.
A system for determining a subject level risk of metastatic cancer of a subject, the system comprising:
- an imaging device configured to capture one or more images of the subject;
- and
- a computing device configured to perform the steps of:
- obtaining one or more images captured from the subject comprising a plurality of lymph nodes of the subject;
- and
- predicting the subject level risk of metastatic cancer by applying a risk model to extracted features of the obtained one or more images, the risk model trained to predict lymph node (LN) level risks of metastatic cancer for lymph nodes in images,
- wherein the risk model is trained using at least labels derived from imputed LN-level risks of metastatic cancer for a set of lymph nodes of a reference individual, the imputed LN-level risks of the set of lymph nodes determined using at least an imputation model that discriminates between cancerous and non-cancerous lymph nodes of training images.
A non-transitory computer readable medium comprising instructions that, when executed by a processor, cause the processor to:
- obtain one or more images captured from the subject comprising a plurality of lymph nodes of the subject;
- and
- predict the subject level risk of metastatic cancer by applying a risk model to extracted features of the obtained one or more images, the risk model trained to predict lymph node (LN) level risks of metastatic cancer for lymph nodes in images,
- wherein the risk model is trained using at least labels derived from imputed LN-level risks of metastatic cancer for a set of lymph nodes of a reference individual, the imputed LN-level risks of the set of lymph nodes determined using at least an imputation model that discriminates between cancerous and non-cancerous lymph nodes of training images.
Dependencies are inferred from the claim text.